The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs

It was an event-filled one for biotech stocks, with the release of a slew of earnings, presentations of clinical trial results and M&A news flow.

Now, here are the upcoming week's key biotech catalysts.

Conferences

• 20th World Congress on Gastroenterology - March 4-5, in Berlin, Germany
• 18th International Conference on Nephrology & Urology - March 4-5, in Berlin
• 24th Annual meet on Surgical Oncology - March 4-5, in Paris, France
• 10th Molecular Immunology & Immunogenetics Congress - March 4-5, in Barcelona, Spain
• Credit Suisse 2019 Global Healthcare Conference – March 5-6, in London
• 32nd Euro Congress on Cancer Science & Therapy - March 7-8, in Barcelona
• 5th International Conference on Mental Health and Human Resilience - March 7-8, 2019 Barcelona

PDUFA Dates

The FDA is likely to rule on Johnson & Johnson (NYSE: JNJ) unit Janssen's treatment-resistant drug Esketamine Monday. A FDA panel that reviewed the investigational drug voted 14-2 in favor of its benefit-risk profile.

Clinical Trial Results

Sesen Bio Inc (NASDAQ: SESN) is due to release additional preliminary Phase 3 data for Vicinium, its treatment candidate for non-muscle invasive bladder cancer Monday.

Myokardia Inc (NASDAQ: MYOK) will release additional interim Phase 2 data for its non-obstructive hypertrophic cardiomyopathy candidate Mavacamten Monday.

Earnings

Monday, March 4

• BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) (before the market open)
• Sesen Bio (before the market open)
• Myokardia (before the market open)
• Adamas Pharmaceuticals Inc (NASDAQ: ADMS) (after the market close)
• La Jolla Pharmaceutical Company (NASDAQ: LJPC) (after the market close)
• Otonomy Inc (NASDAQ: OTIC) (after the market close)

Tuesday, March 5

• Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (before the market open)
• Chimerix Inc (NASDAQ: CMRX) (before the market open)
• Obseva SA (NASDAQ: OBSV) (before the market open)
• Neuronetics Inc (NASDAQ: STIM) (before the market open)
• Fate Therapeutics Inc (NASDAQ: FATE) (after the market close)
• BIOLASE Inc (NASDAQ: BIOL) (after the market close)
• Kura Oncology Inc (NASDAQ: KURA) (after the market close)

Wednesday, March 6

• GlycoMimetics IncNASDAQ: (GLYC) (before the market open)
• Jounce Therapeutics Inc (NASDAQ: JNCE) (before the market open)
• OptiNose Inc (NASDAQ: OPTN) (before the market open)
• Xenon Pharmaceuticals Inc (NASDAQ: XENE) (after the market close)
• Assertio Therapeutics Inc (NASDAQ: ASRT) (after the market close)
• CareDx Inc (NASDAQ: CDNA) (after the market close)
• Evoke Pharma Inc (NASDAQ: EVOK) (after the market close)

See Also: Analysts Laud Sarepta's 'Increasingly Active' Gene Therapy Clinical Development

Thursday, March 7

• Orthopediatrics Corp (NASDAQ: KIDS) (before the market open)
• Albireo Pharma Inc (NASDAQ: ALBO) (before the market open)
• ArQule, Inc. (NASDAQ: ARQL) (before the market open)
• Zai Lab Ltd (NASDAQ: ZLAB) (before the market open)
• Syros Pharmaceuticals Inc (NASDAQ: SYRS) (before the market open)
• Celldex Therapeutics, Inc. (NASDAQ: CLDX) (after the market close)
• Kindred Biosciences Inc N(ASDAQ: KIN) (after the market close)
• Pure Bioscience, Inc. Common Stock (OTC: PURE) (after the market close)
• Ocular Therapeutix Inc (NASDAQ: OCUL) (after the market close)
• Aeglea Bio Therapeutics Inc (NASDAQ: AGLE) (after the market close)
• AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) (after the market close)
• Aravive Inc (NASDAQ: ARAV (after the market close)
• Arbutus Biopharma Corp (NASDAQ: ABUS) (after the market close)
• Geron Corporation (NASDAQ: GERN) (after the market close)
• HTG Molecular Diagnostics Inc (NASDAQ: HTGM)
• Syndax Pharmaceuticals Inc (NASDAQ: SNDX)

Friday, March 8

• Allogene Therapeutics Inc (NASDAQ: ALLO) (before the market open)
• Eloxx Pharmaceuticals Inc (NASDAQ: ELOX) (before the market open)
• PLx Pharma Inc (NASDAQ: PLXP) (before the market open)

IPO

ShockWave Medical, which sells medical devices to treat cardiovascular diseases, is set to offer 5 million shares in an IPO, with an estimated price range of $14-$16. The company expects to list its shares on the Nasdaq under the ticker symbol SWAV.

IPO Quiet Period Expiry

Alector Inc (NASDAQ: ALEC)
Harpoon Therapeutics Inc(NASDAQ: HARP)
Gossamer Bio Inc (NASDAQ: GOSS)
ANCHIANO THERAP/S ADR (NASDAQ: ANCN)